Other OTC - Delayed Quote USD

Herborium Group, Inc. (HBRM)

0.0001 0.0000 (0.00%)
At close: April 22 at 2:43 PM EDT

Key Executives

Amounts are as of December 31, 2007 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Dr. Agnes P. Olszewski Founder, Chairman, CEO, President, CFO & Principal Accounting Officer 150k -- 1957
Dr. James P. Gilligan MSIB, Ph.D. Co-Founder, Scientific Advisor & Director 66.67k -- 1952
Mr. Daniel Teo Senior Vice President of Business Development -- -- --
Mr. Lawrence Woo Asia Business Advisor & Director -- -- --
Mr. Roger Jones UK & EU Advisor and Director -- -- 1943
Mr. John E. Donahue Controller & SEC Advisor -- -- 1950

Herborium Group, Inc.

One Bridge Plaza North
Suite 275
Fort Lee, NJ 07024
United States
201-849-4431 https://www.herborium.com
Sector: 
Healthcare
Full Time Employees: 
2

Description

Herborium Group, Inc., a botanical therapeutics company, develops, licenses, and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. It offers dermatology products, which include AcnEase, herbal medicinal product for enhancing conditions associated with hormonal acne and multiple symptoms of Rosacea; and AcnEase Skin Management System for the treatment of acne marks/scars. The company also provides sexual health and performance products that are non-prescriptive alternatives to selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, and surgical procedures, including hysterectomy. In addition, it offers energy restoration products, such as Lasting Energy, a herbal supplement to decrease the symptoms associated with hangovers and eliminating jet-lag; and for treating overall depletion of energy due to competitive sports, high levels of stress, and extensive sexual activities, as well as other long term or temporary physical demands. Further, the company provides Liver Activator Series for the treatment of liver damage; ProstAid, a natural product focuses on Benign Prostate Hyperplasia; and CardioVitae, a fermentation based product using a Lucidium derived cell line targeting cardio-pulmonary insufficiencies. Herborium Group, Inc. sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce. The company was founded in 2000 and is headquartered in Fort Lee, New Jersey.

Corporate Governance

Herborium Group, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

Feb 15, 2024 - Feb 19, 2024
Herborium Group, Inc. Earnings Call

Related Tickers